Verona, NJ, United States of America

Arnold A Liebman


Average Co-Inventor Count = 2.2

ph-index = 2

Forward Citations = 31(Granted Patents)


Location History:

  • Upper Saddle River, NJ (US) (1977 - 1978)
  • Verona, NJ (US) (1978 - 1989)

Company Filing History:


Years Active: 1977-1989

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Arnold A. Liebman

Introduction

Arnold A. Liebman is a notable inventor based in Verona, NJ (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of seven patents to his name, Liebman has made strides in the development of compounds that have practical applications in medical diagnostics.

Latest Patents

Among his latest patents is the invention of radiolabeled benzazepine, a compound characterized by the formula: ##STR1## wherein T is tritium. This compound is described along with intermediates for its preparation. The utility of this compound lies in its ability to detect the presence of benzodiazepine receptor occupiers in warmblooded animals, making it a valuable tool in medical research and diagnostics.

Career Highlights

Liebman has spent a significant portion of his career at Hoffmann-La Roche Inc., where he has been instrumental in advancing pharmaceutical research. His work has not only contributed to the understanding of benzodiazepine receptors but has also paved the way for new diagnostic methods in the medical field.

Collaborations

Throughout his career, Liebman has collaborated with esteemed colleagues such as Yu-Ying Liu and Walter Burger. These collaborations have enhanced the research and development of innovative compounds, further solidifying his reputation in the industry.

Conclusion

Arnold A. Liebman's innovative work in the field of pharmaceuticals, particularly with his patents on radiolabeled benzazepine, showcases his dedication to advancing medical science. His contributions continue to have a lasting impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…